{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:09:00Z","timestamp":1783487340662,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.bmcl.2016.01.019","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T14:00:33Z","timestamp":1452261633000},"page":"1292-1295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases"],"prefix":"10.1016","volume":"26","author":[{"given":"Masanori","family":"Tobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2016.01.019_b0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","volume":"118","author":"Akdis","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bmcl.2016.01.019_b0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1185\/03007990903512156","volume":"26","author":"Simpson","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bmcl.2016.01.019_h0015","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0968-0896(00)00126-7","volume":"8","author":"Tobe","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2016.01.019_h0020","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1016\/j.bmc.2003.09.012","volume":"11","author":"Isobe","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2016.01.019_h0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2133.2002.04917.x","volume":"147","author":"Inoue","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bmcl.2016.01.019_b0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(02)01340-7","volume":"438","author":"Goto","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bmcl.2016.01.019_h0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/1523-1747.ep12613740","volume":"99","author":"Trenam","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bmcl.2016.01.019_h0040","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signalling"},{"key":"10.1016\/j.bmcl.2016.01.019_h0045","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/chir.20399","volume":"19","author":"McConnell","year":"2007","journal-title":"Chirality"},{"key":"10.1016\/j.bmcl.2016.01.019_h0050","unstructured":"FDA\u2019s guidance for the development of new stereoisomeric drugs can be found at: http:\/\/www.fda.gov\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm122883.htm."},{"key":"10.1016\/j.bmcl.2016.01.019_h0055","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/jm030062a","volume":"46","author":"Tamura","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2016.01.019_h0060","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.bmcl.2008.02.038","volume":"18","author":"Niki","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2016.01.019_h0065","unstructured":"Ohuchida, S.; Nambu, F.; Toda, M. JP Patent 07,112,980, 1995"},{"key":"10.1016\/j.bmcl.2016.01.019_h0070","unstructured":"Hasegawa, T.; Hachitani, K.; Nambu, F.; Onada, S. JP Patent 08,109,179, 1996."},{"key":"10.1016\/j.bmcl.2016.01.019_b0040","unstructured":"Isobe, Y.; Tobe, M.; Isobe, M. WO Patent 026,842, 2004."},{"key":"10.1016\/j.bmcl.2016.01.019_b0045","unstructured":"Hirose, N.; Nakamura, T.; Banba, T.; Margaret, D.; Nakamura, T.; Sano, Y.; Miyauchi, Y.; Kijima, S. JP Patent 05,178,848, 1993."},{"key":"10.1016\/j.bmcl.2016.01.019_b0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cber.19600930115","volume":"93","author":"Rieche","year":"1960","journal-title":"Chem. Ber."},{"key":"10.1016\/j.bmcl.2016.01.019_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.2002.04803.x","volume":"147","author":"Toyoda","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bmcl.2016.01.019_b0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)00780-B","volume":"275","author":"Kuraishi","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bmcl.2016.01.019_b0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1523-1747.ep12515092","volume":"71","author":"H\u00e4germark","year":"1978","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bmcl.2016.01.019_b0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(00)00349-6","volume":"400","author":"Inagaki","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bmcl.2016.01.019_b0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12264-012-1207-9","volume":"28","author":"Liu","year":"2012","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bmcl.2016.01.019_b0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1523-1747.2003.12250.x","volume":"120","author":"Uchi","year":"2003","journal-title":"J. Invest. Dermatol."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X16300191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X16300191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:05:27Z","timestamp":1760771127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X16300191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0960894X16300191"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2016.01.019","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2016.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}